Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma

Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma

27 May 2022 5:11 PM | Anonymous

Tomoki Abe MD, Taro Oshikiri MD, Hironobu Goto MD, Takashi Kato MD, Manabu Horikawa MD, Ryuichiro Sawada MD, Hitoshi Harada MD, Naoki Urakawa MD, Hiroshi Hasegawa MD, Shingo Kanaji MD, Kimihiro Yamashita MD, Takeru Matsuda MD, Tetsu Nakamura MD & Yoshihiro Kakeji MD 

Read Abstract: Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software